Bill

Bill > HB1523


MD HB1523

MD HB1523
Alcohol, Tobacco, and Cannabis Commission - Unauthorized Consumable Products - Enforcement and Seizure


summary

Introduced
02/13/2026
In Committee
02/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

Altering the violations of law with respect to which the Field Enforcement Division of the Alcohol, Tobacco, and Cannabis Commission is authorized to issue a citation or charging document; prohibiting a retailer from distributing, selling, exposing for sale, or advertising for sale unauthorized consumable products; authorizing the Executive Director of the Commission to seize, confiscate, or destroy unauthorized consumable products and certain other products; etc.

AI Summary

This bill expands the enforcement powers of the Alcohol, Tobacco, and Cannabis Commission's Field Enforcement Division by allowing them to issue citations for violations related to unauthorized consumable products, which include specific types of tianeptine, kratom, and phenibut products, as well as any product containing poisonous substances. It also prohibits retailers from selling, distributing, or advertising these unauthorized consumable products, defining "retailer" broadly to include various businesses involved in their sale or preparation. The Executive Director of the Commission is authorized to seize, confiscate, and destroy these unauthorized products, which are presumed to be contraband unless proven to be approved for human consumption by the Maryland Department of Health or the U.S. Food and Drug Administration. Retailers violating these provisions face misdemeanor charges with potential fines, imprisonment, and civil liability for damages, and their licenses may be suspended or revoked. Additionally, the bill clarifies that displaying or offering an unauthorized consumable product for sale is considered prima facie evidence of selling it, and it also updates regulations regarding the advertising and marketing of kratom and phenibut products, particularly to minors, and requires the Department of Health to notify the Commission of any changes in the regulatory status of these products.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

House Health Hearing (13:00:00 3/3/2026 ) (on 03/03/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...